Grant Sweep

We sweep the internet for research funding across disease areas and research fields — federal, foundation, state & industry sources in one filterable place.

← Back to opportunities
OpenUG3Clinical trial: Required

NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)

National Institutes of Health (NIH) · NIH Institute/Center · PAR-27-065

Source: Grants.gov · View original posting ↗

Award
Amount not listed
Deadline
Mar 9, 2029
Letter of intent
Mechanism
UG3
Duration
Expected awards
Funding cycle
Standard NIH dates
Open date
Aug 31, 2026
Total funding
Clinical trial
Required
Small businessHigher educationNonprofitGovernmentForeign entities

Research areas

Therapeutics & drug discoveryClinical trials

Auto-classified from the title and description (keyword-based) — may be imperfect.

Description

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). These trials must address questions within the mission and research interests of the NINDS and may include studies of small molecules, biologics, devices as well as surgical, behavioral, diet-based, or rehabilitation therapies. Studies addressing neurological diseases and care across the lifespan are highly encouraged. This notice invites both early- and middle-phase exploratory clinical trials as well as later phase confirmatory Phase 3 or comparative effectiveness clinical trials.

Data notes: award amount not published in the source feed; administering NIH institute could not be identified from the opportunity number.